If delinquency proceedings have been taken against a protected cell captive insurance company:
(1) the assets of a protected cell may not be used to pay any expenses other than those attributable to the protected cell; and
(2) the capital and surplus of the protected cell captive insurance company must be available at all times to pay expenses of or claims against the protected cell captive insurance company.